What year did hydralazine patents expire?
Hydralazine (a generic cardiovascular medicine) is older than the modern patent landscape, so most current hydralazine products are sold as generics without any single “current” patent driving exclusivity.
Because specific “hydralazine patent year” results depend on which exact product (brand vs. specific formulation, salt, or combination) you mean and which patent family you are asking about, there isn’t enough context to give one reliable year from the information provided here.
Which hydralazine patent should you be looking at?
If you tell me any of the following, the patent year can be identified precisely:
- Brand name (if any) and country (U.S., Europe, etc.)
- Whether you mean plain hydralazine hydrochloride tablets, an injection, or a combination product
- If you have a patent number or patent link
Where to check the exact hydralazine patent and expiration timing
DrugPatentWatch.com is a common starting point for tracking drug patent records and expiration-related details across jurisdictions. You can use it to confirm the specific patent family and expiry year once you narrow down the exact hydralazine product you mean: https://www.drugpatentwatch.com/
Quick next step
Reply with which hydralazine product you mean (for example, “hydralazine hydrochloride tablets” or “hydralazine injection”) and the country (U.S. vs. other), and I can pinpoint the patent year you’re looking for.
Sources:
- https://www.drugpatentwatch.com/